These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 467888)

  • 1. Lymphocyte responsiveness to phytohemagglutinin and its modification by serum inhibitor in breast cancer patients.
    Toge T; Nagusa Y; Nakano A; Ikeda H; Hattori T
    Gan; 1979 Apr; 70(2):245-8. PubMed ID: 467888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of lymphocyte response to PHA in patients with operable breast carcinoma: effect of cell concentration, PHA dose, serum and period of cultivation.
    Harrison RA; Lee H; Farrant J
    Clin Oncol; 1981 Sep; 7(3):205-12. PubMed ID: 7343166
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between lymphocyte responsiveness to mitogens and results of chemo-immunotherapy in patients with advanced cancer.
    Toge T; Yamada Y; Ikeda H; Niimoto M; Hattori T
    Gan; 1979 Oct; 70(5):699-703. PubMed ID: 520761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
    Nakao S; Hayashida K; Hasegawa H; Ishii T; Eida K; Noguchi K
    Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer.
    Margolese RG; Wainberg MA
    Clin Exp Immunol; 1985 Oct; 62(1):85-94. PubMed ID: 2998661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lymphocyte immunity in breast cancer patients.
    Head JF; Elliott RL; McCoy JL
    Breast Cancer Res Treat; 1993; 26(1):77-88. PubMed ID: 8400326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
    Kastelan M; Rudolf M; Hrsak M; Stojkovic R; Gamulin S
    Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
    Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
    J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer.
    Toge T; Ikeda H; Senoo N; Niimoto M; Hattori T
    Jpn J Surg; 1976 Dec; 6(4):157-63. PubMed ID: 1018347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
    Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of lymphocyte responses to phytohemagglutinin in melanoma patients. (lack o prognostic value of correlation with minimal tumor burden).
    Kovarík J; Ninger E; Zemanová D; Lauerová L
    Neoplasma; 1980; 27(5):575-82. PubMed ID: 7231613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active lymphocyte traffic induced in the periphery by cytokines and phytohemagglutinin: three different mechanisms?
    Binns RM; Licence ST; Wooding FB; Duffus WP
    Eur J Immunol; 1992 Sep; 22(9):2195-203. PubMed ID: 1516613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHA responsiveness and adherent cell-lymphocyte interactions in patients with advanced malignant tumors of the ovary prior to treatment and during chemotherapy.
    Markowska J; Jaroszewski J; Jankowiak S; Wiktorowicz K; Jaskulska T
    Neoplasma; 1986; 33(3):361-9. PubMed ID: 3736722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent responsiveness of T lymphocytes to allogeneic and PHA stimulation.
    Onody C; Bátory G; Patrányi GG
    Thymus; 1980 Jan; 1(4-5):205-13. PubMed ID: 6969472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.